These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37197026)

  • 1. Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection.
    Vaughan HJ; Zamboni CG; Luly KM; Li L; Gabrielson KL; Hassan LF; Radant NP; Bhardwaj P; Selaru FM; Pomper MG; Green JJ
    Int J Nanomedicine; 2023; 18():2525-2537. PubMed ID: 37197026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma.
    Zamboni CG; Kozielski KL; Vaughan HJ; Nakata MM; Kim J; Higgins LJ; Pomper MG; Green JJ
    J Control Release; 2017 Oct; 263():18-28. PubMed ID: 28351668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ethylene glycol)-Poly(beta-amino ester)-Based Nanoparticles for Suicide Gene Therapy Enhance Brain Penetration and Extend Survival in a Preclinical Human Glioblastoma Orthotopic Xenograft Model.
    Kim J; Mondal SK; Tzeng SY; Rui Y; Al-Kharboosh R; Kozielski KK; Bhargav AG; Garcia CA; Quiñones-Hinojosa A; Green JJ
    ACS Biomater Sci Eng; 2020 May; 6(5):2943-2955. PubMed ID: 33463272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoscale CaO
    Wang Y; He X; Zhou C; Bai Y; Li T; Liu J; Ju S; Wang C; Xiang G; Xiong B
    Acta Biomater; 2022 Dec; 154():536-548. PubMed ID: 36241014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma.
    He Q; Liu Y; Zou Q; Guan YS
    World J Gastroenterol; 2011 May; 17(18):2353-5. PubMed ID: 21633603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
    Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
    World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma.
    Vaughan HJ; Zamboni CG; Hassan LF; Radant NP; Jacob D; Mease RC; Minn I; Tzeng SY; Gabrielson KL; Bhardwaj P; Guo X; Francisco D; Pomper MG; Green JJ
    Sci Adv; 2022 Jul; 8(29):eabo6406. PubMed ID: 35857843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series.
    Lekht I; Nayyar M; Luu B; Guichet PL; Ho J; Ter-Oganesyan R; Katz M; Gulati M
    Abdom Radiol (NY); 2017 May; 42(5):1400-1407. PubMed ID: 28008454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
    Xia X; Li X; Feng G; Zheng C; Liang H; Zhou G
    Acta Radiol; 2013 Jul; 54(6):684-9. PubMed ID: 23507934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol.
    Vogl TJ; Oppermann E; Qian J; Imlau U; Tran A; Hamidavi Y; Korkusuz H; Bechstein WO; Nour-Eldin NE; Gruber-Rouh T; Hammerstingl R; Naguib NN
    BMC Cancer; 2016 May; 16():325. PubMed ID: 27215551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma.
    Wei X; Zhao L; Ren R; Ji F; Xue S; Zhang J; Liu Z; Ma Z; Wang XW; Wong L; Liu N; Shi J; Guo X; Roessler S; Zheng X; Ji J
    Hepatology; 2021 Apr; 73(4):1381-1398. PubMed ID: 32609900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Shin SW
    Korean J Radiol; 2009; 10(5):425-34. PubMed ID: 19721826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients.
    Song MJ; Park CH; Kim JD; Kim HY; Bae SH; Choi JY; Yoon SK; Chun HJ; Choi BG; Lee HG
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):521-7. PubMed ID: 21537127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
    Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy.
    Lym JS; Nguyen QV; Ahn da W; Huynh CT; Jae HJ; Kim YI; Lee DS
    Acta Biomater; 2016 Sep; 41():253-63. PubMed ID: 27184404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.
    Kallini JR; Gabr A; Ali R; Abouchaleh N; Riaz A; Baker T; Kulik L; Caicedo J; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results].
    Vogl TJ; Zangos S; Balzer JO; Nabil M; Rao P; Eichler K; Bechstein WO; Zeuzem S; Abdelkader A
    Rofo; 2007 Nov; 179(11):1113-26. PubMed ID: 17948190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.
    Li J; Zhou M; Liu F; Xiong C; Wang W; Cao Q; Wen X; Robertson JD; Ji X; Wang YA; Gupta S; Li C
    Radiology; 2016 Nov; 281(2):427-435. PubMed ID: 27347765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.